{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T10:50:49Z","timestamp":1790851849057,"version":"4.1.0"},"reference-count":49,"publisher":"American Society of Hematology","issue":"2","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2002,7,15]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The 558-565 loop region in the A2 subunit of factor (F) VIIIa forms a direct interface with FIXa. We have expressed and purified B-domainless FVIII (FVIIIWT) and B-domainless FVIII containing the hemophilia A\u2013associated mutations Ser558Phe, Val559Ala, Asp560Ala, Gln565Arg, and the activated protein C cleavage site mutant Arg562Ala. Titration of FVIIIa in FXa generation assays showed that the mutant and wild-type proteins had similar functional affinities for FIXa (dissociation constant [Kd] values \u223c5 nM-20 nM and \u223c100 nM-250 nM in the presence and absence of phospholipid, respectively). The catalytic activities of the factor Xase complex composed of the hemophilia A\u2013associated FVIII species were markedly reduced both in the presence and absence of phospholipid. FVIIIWT and FVIIIArg562Ala showed catalytic rate constant (kcat) values of approximately 60 minute\u22121 in the presence of phospholipid, whereas the hemophilia A\u2013associated mutants showedkcat values ranging from 3.3 minute\u22121 to 7.5 minute\u22121. In the absence of phospholipid, all kcat values were reduced but FVIIIWT and FVIIIArg562Ala retained higher activities as compared with the hemophilic mutant FVIII forms. Fluorescence anisotropy experiments using fluorescein-modified FIXa confirmed that all FVIII forms interacted with FIXa. However, the presence of factor X yielded minimal increases in anisotropy observed with the mutant factor VIII forms, consistent with their reduced activity. These results show that residues within the 558-565 loop are critical in modulating FIXa enzymatic activity but do not contribute significantly to the affinity of FVIIIa for FIXa.<\/jats:p>","DOI":"10.1182\/blood-2001-12-0361","type":"journal-article","created":{"date-parts":[[2002,10,11]],"date-time":"2002-10-11T18:33:52Z","timestamp":1034361232000},"page":"501-508","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":56,"title":["Mutations associated with hemophilia A in the 558-565 loop of the factor VIIIa A2 subunit alter the catalytic activity of the factor Xase complex"],"prefix":"10.1182","volume":"100","author":[{"given":"P. Vincent","family":"Jenkins","sequence":"first","affiliation":[{"name":"From the Department of Biochemistry and Biophysics and the Department of Medicine, University of Rochester Medical Center, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Freas","sequence":"additional","affiliation":[{"name":"From the Department of Biochemistry and Biophysics and the Department of Medicine, University of Rochester Medical Center, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyla M.","family":"Schmidt","sequence":"additional","affiliation":[{"name":"From the Department of Biochemistry and Biophysics and the Department of Medicine, University of Rochester Medical Center, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zhou","sequence":"additional","affiliation":[{"name":"From the Department of Biochemistry and Biophysics and the Department of Medicine, University of Rochester Medical Center, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip J.","family":"Fay","sequence":"additional","affiliation":[{"name":"From the Department of Biochemistry and Biophysics and the Department of Medicine, University of Rochester Medical Center, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2020021219074106200_B1","doi-asserted-by":"crossref","first-page":"10363","DOI":"10.1021\/bi00107a001","article-title":"The coagulation cascade: initiation, maintenance, and regulation.","volume":"30","author":"Davie","year":"1991","journal-title":"Biochemistry."},{"key":"2020021219074106200_B2","doi-asserted-by":"crossref","first-page":"5939","DOI":"10.1073\/pnas.83.16.5939","article-title":"A large region (approximately equal to 95 kDa) of human factor VIII is dispensible for in vitro procoagulant activity.","volume":"83","author":"Toole","year":"1986","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2020021219074106200_B3","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/312330a0","article-title":"Expression of active human factor VIII from recombinant DNA clones.","volume":"312","author":"Wood","year":"1984","journal-title":"Nature."},{"key":"2020021219074106200_B4","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1182\/blood.V59.3.594.594","article-title":"Monoclonal antibodies to porcine factor VIII coagulant and their use in the isolation of active coagulant protein.","volume":"59","author":"Fass","year":"1982","journal-title":"Blood."},{"key":"2020021219074106200_B5","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1073\/pnas.83.9.2979","article-title":"Isolation and characterization of human factor VIII: molecular forms in commercial factor VIII concentrate, cryoprecipitate, and plasma.","volume":"83","author":"Andersson","year":"1986","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2020021219074106200_B6","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/0167-4838(86)90208-6","article-title":"The size of human factor VIII heterodimers and the effects produced by thrombin.","volume":"871","author":"Fay","year":"1986","journal-title":"Biochim Biophys Acta."},{"key":"2020021219074106200_B7","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1021\/bi00350a035","article-title":"Proteolytic processing of human factor VIII: correlation of specific cleavages by thrombin, factor Xa, and activated protein C with activation and inactivation of factor VIII coagulant activity.","volume":"25","author":"Eaton","year":"1986","journal-title":"Biochemistry."},{"key":"2020021219074106200_B8","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1021\/bi00428a038","article-title":"Subunit structure of thrombin-activated porcine factor VIII.","volume":"28","author":"Lollar","year":"1989","journal-title":"Biochemistry."},{"key":"2020021219074106200_B9","doi-asserted-by":"crossref","first-page":"8957","DOI":"10.1016\/S0021-9258(18)31537-0","article-title":"Human factor VIIIa subunit structure: reconstitution of factor VIIIa from the isolated A1\/A3\u2013C1-C2 dimer and A2 subunit.","volume":"266","author":"Fay","year":"1991","journal-title":"J Biol Chem."},{"key":"2020021219074106200_B10","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1182\/blood.V92.11.3983","article-title":"The life cycle of coagulation factor VIII in view of its structure and function.","volume":"92","author":"Lenting","year":"1998","journal-title":"Blood."},{"key":"2020021219074106200_B11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/blood.V76.1.1.1","article-title":"Surface-dependent reactions of the vitamin K-dependent enzyme complexes.","volume":"76","author":"Mann","year":"1990","journal-title":"Blood."},{"key":"2020021219074106200_B12","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.1016\/S0021-9258(19)69627-4","article-title":"The role of phospholipid and factor VIIIa in the activation of bovine factor X.","volume":"256","author":"van Dieijen","year":"1981","journal-title":"J Biol Chem."},{"key":"2020021219074106200_B13","doi-asserted-by":"crossref","first-page":"19049","DOI":"10.1074\/jbc.273.30.19049","article-title":"The A2 subunit of factor VIIIa modulates the active site of factor IXa.","volume":"273","author":"Fay","year":"1998","journal-title":"J Biol Chem."},{"key":"2020021219074106200_B14","doi-asserted-by":"crossref","first-page":"20522","DOI":"10.1016\/S0021-9258(17)32024-0","article-title":"Factor VIIIa A2 subunit residues 558-565 represent a factor IXa interactive site.","volume":"269","author":"Fay","year":"1994","journal-title":"J Biol Chem."},{"key":"2020021219074106200_B15","doi-asserted-by":"crossref","first-page":"27087","DOI":"10.1074\/jbc.270.45.27087","article-title":"Localization of factor IXa and factor VIIIa interactive sites.","volume":"270","author":"O'Brien","year":"1995","journal-title":"J Biol Chem."},{"key":"2020021219074106200_B16","doi-asserted-by":"crossref","first-page":"20139","DOI":"10.1016\/S0021-9258(18)54901-2","article-title":"Activated protein C-catalyzed inactivation of human factor VIII and factor VIIIa: identification of cleavage sites and correlation of proteolysis with cofactor activity.","volume":"266","author":"Fay","year":"1991","journal-title":"J Biol Chem."},{"key":"2020021219074106200_B17","doi-asserted-by":"crossref","first-page":"9445","DOI":"10.1016\/S0021-9258(17)36901-6","article-title":"Factor IXa protects factor VIIIa from activated protein C; factor IXa inhibits activated protein C-catalyzed cleavage of factor VIIIa at Arg562.","volume":"269","author":"Regan","year":"1994","journal-title":"J Biol Chem."},{"key":"2020021219074106200_B18","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1093\/nar\/25.1.128","article-title":"The factor VIII mutation database on the world wide web: the haemophilia A mutation, search, test and resource site. HAMSTeRS update (version 3.0).","volume":"25","author":"Kemball-Cook","year":"1997","journal-title":"Nucl Acid Res."},{"key":"2020021219074106200_B19","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1021\/bi00507a028","article-title":"Phospholipid vesicle formation and transmembrane protein incorporation using octyl glucoside.","volume":"20","author":"Mimms","year":"1981","journal-title":"Biochemistry."},{"key":"2020021219074106200_B20","first-page":"107","article-title":"Artificial substrate for the assay of factors V and VIII.","volume":"4","author":"Casillas","year":"1971","journal-title":"Coagulation."},{"key":"2020021219074106200_B21","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.","volume":"72","author":"Bradford","year":"1976","journal-title":"Analytical Biochemistry."},{"key":"2020021219074106200_B22","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of bacteriophage T4.","volume":"227","author":"Laemmli","year":"1970","journal-title":"Nature."},{"key":"2020021219074106200_B23","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0167-4838(01)00225-4","article-title":"Factor VIIIa cofactor activity shows enhanced ionic strength sensitivity in the absence of phospholipid.","volume":"1548","author":"Fay","year":"2001","journal-title":"Biochim Biophys Acta."},{"key":"2020021219074106200_B24","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1006\/geno.1993.1200","article-title":"Sequence of the murine factor VIII cDNA.","volume":"16","author":"Elder","year":"1993","journal-title":"Genomics."},{"key":"2020021219074106200_B25","doi-asserted-by":"crossref","first-page":"4209","DOI":"10.1182\/blood.V88.11.4209.bloodjournal88114209","article-title":"The cDNA and derived amino acid sequence of porcine factor VIII.","volume":"88","author":"Healey","year":"1996","journal-title":"Blood."},{"key":"2020021219074106200_B26","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1055\/s-0037-1614984","article-title":"The canine factor VIII cDNA and 5' flanking sequence.","volume":"79","author":"Cameron","year":"1998","journal-title":"Thromb Haemost."},{"key":"2020021219074106200_B27","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/312337a0","article-title":"Structure of human factor VIII.","volume":"312","author":"Vehar","year":"1984","journal-title":"Nature."},{"key":"2020021219074106200_B28","doi-asserted-by":"crossref","first-page":"11970","DOI":"10.1074\/jbc.M008046200","article-title":"Cell surface heparan sulfate proteoglycans participate in factor VIII catabolism mediated by low density lipoprotein receptor-related protein.","volume":"276","author":"Sarafanov","year":"2001","journal-title":"J Biol Chem."},{"key":"2020021219074106200_B29","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1093\/nar\/26.1.216","article-title":"The factor VIII structure and mutation resource site: HAMSTeRS version 4.","volume":"26","author":"Kemball-Cook","year":"1998","journal-title":"Nucl Acid Res."},{"key":"2020021219074106200_B30","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1182\/blood.V91.2.538","article-title":"The molecular basis for cross-reacting material-positive hemophilia A due to missense mutations within the A2-domain of factor VIII.","volume":"91","author":"Amano","year":"1998","journal-title":"Blood."},{"key":"2020021219074106200_B31","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0021-9258(19)40122-1","article-title":"Binding of human factor VIII to phospholipid vesicles.","volume":"265","author":"Gilbert","year":"1990","journal-title":"J Biol Chem."},{"key":"2020021219074106200_B32","doi-asserted-by":"crossref","first-page":"17261","DOI":"10.1016\/S0021-9258(19)47368-7","article-title":"Platelet-derived microparticles express high affinity receptors for factor VIII.","volume":"266","author":"Gilbert","year":"1991","journal-title":"J Biol Chem."},{"key":"2020021219074106200_B33","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1182\/blood.V75.10.1999.1999","article-title":"Synthetic factor VIII peptides with amino acid sequences contained within the C2 domain of factor VIII inhibit factor VIII binding to phosphatidylserine.","volume":"75","author":"Foster","year":"1990","journal-title":"Blood."},{"key":"2020021219074106200_B34","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/46601","article-title":"Structure of the C2 domain of human factor VIII at 1.5 A resolution.","volume":"402","author":"Pratt","year":"1999","journal-title":"Nature."},{"key":"2020021219074106200_B35","doi-asserted-by":"crossref","first-page":"12048","DOI":"10.1021\/bi00206a006","article-title":"High-affinity, specific factor IXa binding to platelets is mediated in part by residues 3-11.","volume":"33","author":"Ahmad","year":"1994","journal-title":"Biochemistry."},{"key":"2020021219074106200_B36","doi-asserted-by":"crossref","first-page":"16227","DOI":"10.1074\/jbc.271.27.16227","article-title":"Identification of the phospholipid binding site in the vitamin K-dependent blood coagulation protein factor IX.","volume":"271","author":"Freedman","year":"1996","journal-title":"J Biol Chem."},{"key":"2020021219074106200_B37","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1021\/bi00462a025","article-title":"Kinetics of coagulation factor X activation by platelet-bound factor IXa.","volume":"29","author":"Rawala-Sheikh","year":"1990","journal-title":"Biochemistry."},{"key":"2020021219074106200_B38","doi-asserted-by":"crossref","first-page":"11120","DOI":"10.1074\/jbc.271.19.11120","article-title":"Activation of the factor VIIIa-factor IXa enzyme complex of blood coagulation by membranes containing phosphatidyl-L-serine.","volume":"271","author":"Gilbert","year":"1996","journal-title":"J Biol Chem."},{"key":"2020021219074106200_B39","doi-asserted-by":"crossref","first-page":"23418","DOI":"10.1074\/jbc.272.37.23418","article-title":"Interaction of factor IXa with factor VIIIa: effects of protease domain Ca2+ binding site, proteolysis in the autolysis loop, phospholipid, and factor X.","volume":"272","author":"Mathur","year":"1997","journal-title":"J Biol Chem."},{"key":"2020021219074106200_B40","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1074\/jbc.271.4.1935","article-title":"The sequence Glu1811-Lys1818 of human blood coagulation factor VIII comprises a binding site for activated factor IX.","volume":"271","author":"Lenting","year":"1996","journal-title":"J Biol Chem."},{"key":"2020021219074106200_B41","doi-asserted-by":"crossref","first-page":"16302","DOI":"10.1074\/jbc.M011680200","article-title":"Factor IXa:factor VIIIa interaction: helix 330-338 of factor ixa interacts with residues 558-565 and spatially adjacent regions of the a2 subunit of factor VIIIa.","volume":"276","author":"Bajaj","year":"2001","journal-title":"J Biol Chem."},{"key":"2020021219074106200_B42","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1172\/JCI117259","article-title":"Inhibition of human factor VIIIa by anti-A2 subunit antibodies.","volume":"93","author":"Lollar","year":"1994","journal-title":"J Clin Invest."},{"key":"2020021219074106200_B43","doi-asserted-by":"crossref","first-page":"7150","DOI":"10.1016\/S0021-9258(17)37260-5","article-title":"Identification of a binding site for blood coagulation factor IXa on the light chain of human factor VIII.","volume":"269","author":"Lenting","year":"1994","journal-title":"J Biol Chem."},{"key":"2020021219074106200_B44","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1055\/s-0037-1615835","article-title":"Factor VIII-factor IX interactions: molecular sites involved in enzyme-cofactor complex assembly.","volume":"82","author":"Mertens","year":"1999","journal-title":"Thromb Haemostasis."},{"key":"2020021219074106200_B45","doi-asserted-by":"crossref","first-page":"18477","DOI":"10.1074\/jbc.274.26.18477","article-title":"Protease and EGF1 domains of factor IXa play distinct roles in binding to factor VIIIa: importance of helix 330 (helix 162 in chymotrypsin) of protease domain of factor IXa in its interaction with factor VIIIa.","volume":"274","author":"Mathur","year":"1999","journal-title":"J Biol Chem."},{"key":"2020021219074106200_B46","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1042\/bj3390217","article-title":"Regions 301-303 and 333-339 in the catalytic domain of blood coagulation factor IX are factor VIII-interactive sites involved in stimulation of enzyme activity.","volume":"339","author":"Kolkman","year":"1999","journal-title":"Biochem J."},{"key":"2020021219074106200_B47","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1055\/s-0037-1614944","article-title":"Mutation at either Arg336 or Arg562 in factor VIII is insufficient for complete resistance to activated protein C (APC)-mediated inactivation: implications for the APC resistance test.","volume":"79","author":"Amano","year":"1998","journal-title":"Thromb Haemostasis."},{"key":"2020021219074106200_B48","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/S0140-6736(94)92940-8","article-title":"Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosis.","volume":"343","author":"Zoller","year":"1994","journal-title":"Lancet."},{"key":"2020021219074106200_B49","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1182\/blood.V89.7.2413","article-title":"A molecular model for the triplicated A domains of human factor VIII based on the crystal structure of human ceruloplasmin.","volume":"89","author":"Pemberton","year":"1997","journal-title":"Blood."}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/100\/2\/501\/1683674\/h81402000501.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/100\/2\/501\/1683674\/h81402000501.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T04:20:18Z","timestamp":1622089218000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/100\/2\/501\/89002\/Mutations-associated-with-hemophilia-A-in-the"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,7,15]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2002,7,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2001-12-0361","relation":{},"ISSN":["1528-0020","0006-4971"],"issn-type":[{"value":"1528-0020","type":"electronic"},{"value":"0006-4971","type":"print"}],"subject":[],"published":{"date-parts":[[2002,7,15]]}}}